Literature DB >> 1816

Structure and specificity of antibody molecules.

R J Poljak, L M Amzel, B L Chen, R P Phizackerley, F Saul.   

Abstract

The structure of the Fab' fragment of a human myeloma protein (IgG1 (lambda) New) has been determined by X-ray crystallographic analysis to a nominal resolution of 0.2 nm. Each of the structure subunits corresponding to the variable and to the constant homology regions of the light and heavy polypeptide chains contains two irregular beta-sheets which are roughly parallel to each other and surround a tighly packed interior of hydrophobic side chains. The regions of the hypervariable sequences in the light and heavy chains occur in close spatial proximity at one end of the molecule, defining the active site of IgG New. The role of these hypervariable regions in defining the size and shape of the active site of different immunoglobulins is discussed on the basis of the three-dimensional model of Fab' New. Several ligands that bind to the active centre of IgG New have been used to obtain crystalline ligand-Fab' New complexes which were investigated by difference Fourier maps. These studies are analysed in terms of the biological function and specificity of antibodies.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1816     DOI: 10.1098/rstb.1975.0069

Source DB:  PubMed          Journal:  Philos Trans R Soc Lond B Biol Sci        ISSN: 0962-8436            Impact factor:   6.237


  3 in total

1.  Protein Crystallography from the Perspective of Technology Developments.

Authors:  Xiao-Dong Su; Heng Zhang; Thomas C Terwilliger; Anders Liljas; Junyu Xiao; Yuhui Dong
Journal:  Crystallogr Rev       Date:  2015       Impact factor: 2.467

Review 2.  The Hard Way towards an Antibody-Based HIV-1 Env Vaccine: Lessons from Other Viruses.

Authors:  Oliver Ringel; Vincent Vieillard; Patrice Debré; Jutta Eichler; Hildegard Büning; Ursula Dietrich
Journal:  Viruses       Date:  2018-04-15       Impact factor: 5.048

3.  Structure based antibody-like peptidomimetics.

Authors:  Ramachandran Murali; Mark I Greene
Journal:  Pharmaceuticals (Basel)       Date:  2012-02-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.